Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support.

Autor: Szkukalek, Judita1 (AUTHOR) tjudit84@yahoo.com, Dóczi, Róbert2 (AUTHOR) robert.doczi@oncompassmedicine.com, Dirner, Anna2 (AUTHOR) anna.dirner@oncompassmedicine.com, Boldizsár, Ákos2 (AUTHOR) akos.boldizsar@oncompassmedicine.com, Varga, Ágnes2 (AUTHOR) agnes.varga@oncompassmedicine.com, Déri, Júlia2 (AUTHOR) julia.deri@oncompassmedicine.com, Lakatos, Dóra2 (AUTHOR) dora.lakatos@oncompassmedicine.com, Tihanyi, Dóra2 (AUTHOR) dora.tihanyi@oncompassmedicine.com, Vodicska, Barbara2 (AUTHOR) barbara.vodicska@oncompassmedicine.com, Schwáb, Richárd2 (AUTHOR) richard.schwab@oncompassmedicine.com, Pajkos, Gábor2 (AUTHOR) gabor.pajkos@oncompassmedicine.com, Várkondi, Edit2 (AUTHOR) edit.varkondi@oncompassmedicine.com, Vályi-Nagy, István3 (AUTHOR) drvnistvan@gmail.com, Valtinyi, Dorottya1 (AUTHOR) valtinyid@gmail.com, Nagy, Zsuzsanna1 (AUTHOR) onkologia@szentimrekorhaz.hu, Peták, István2,4,5 (AUTHOR) istvan.petak@oncompassmedicine.com
Zdroj: Diagnostics (2075-4418). Oct2021, Vol. 11 Issue 10, p1850-1850. 1p.
Databáze: Academic Search Ultimate